{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:41:30Z","timestamp":1791517290271,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073232"],"award-info":[{"award-number":["82073232"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700769"],"award-info":[{"award-number":["81700769"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pathological cardiac hypertrophy is an independent risk factor for heart failure and is considered a target for the treatment of heart failure. However, the mechanisms underlying pathological cardiac hypertrophy remain largely unknown. We aimed to investigate the role of angiopoietin-like protein 8 (ANGPTL8) in pathological cardiac hypertrophy. We found that serum ANGPTL8 levels were significantly increased in hypertensive patients with cardiac hypertrophy and in mice with cardiac hypertrophy induced by Ang II or TAC. Furthermore, the secretion of ANGPTL8 from the liver was increased during hypertrophic processes, which were triggered by Ang II. In the Ang II- and transverse aortic constriction (TAC)-induced mouse cardiac hypertrophy model, ANGPTL8 deficiency remarkably accelerated cardiac hypertrophy and fibrosis with deteriorating cardiac dysfunction. Accordingly, both recombinant human full-length ANGPTL8 (rANGPTL8) protein and ANGPTL8 overexpression significantly mitigated Ang II-induced cell enlargement in primary neonatal rat cardiomyocytes (NRCMs) and H9c2 cells. Mechanistically, the antihypertrophic effects of ANGPTL8 depended on inhibiting Akt and GSK-3\u03b2 activation, and the Akt activator SC-79 abolished the antihypertrophic effects of rANGPTL8 in vitro. Moreover, we demonstrated that ANGPTL8 directly bound to the paired Ig-like receptor PIRB (LILRB3) by RNA-seq and immunoprecipitation-mass screening. Remarkably, the antihypertrophic effects of ANGPTL8 were largely blocked by anti-LILRB3 and siRNA-LILRB3. Our study indicated that ANGPTL8 served as a novel negative regulator of pathological cardiac hypertrophy by binding to LILRB3 (PIRB) and inhibiting Akt\/GSK3\u03b2 activation, suggesting that ANGPTL8 may provide synergistic effects in combination with AT1 blockers and become a therapeutic target for cardiac hypertrophy and heart failure.<\/jats:p>","DOI":"10.1038\/s41419-022-05029-8","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T15:07:18Z","timestamp":1658156838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["ANGPTL8 is a negative regulator in pathological cardiac hypertrophy"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6719-6613","authenticated-orcid":false,"given":"Lin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1591-7626","authenticated-orcid":false,"given":"Junming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingrong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3921-9643","authenticated-orcid":false,"given":"Qiufang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"5029_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.freeradbiomed.2018.05.004","volume":"121","author":"L Wu","year":"2018","unstructured":"Wu L, Gao L, Zhang D, Yao R, Huang Z, Du B, et al. C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway. Free Radic Biol Med. 2018;121:215\u201330.","journal-title":"Free Radic Biol Med"},{"key":"5029_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"BC Bernardo","year":"2010","unstructured":"Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharm Ther. 2010;128:191\u2013227.","journal-title":"Pharm Ther"},{"key":"5029_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1471-4914(03)00114-X","volume":"9","author":"O Ritter","year":"2003","unstructured":"Ritter O, Neyses L. The molecular basis of myocardial hypertrophy and heart failure. Trends Mol Med. 2003;9:313\u201321.","journal-title":"Trends Mol Med"},{"key":"5029_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/14728222.2019.1575363","volume":"23","author":"M Lieu","year":"2019","unstructured":"Lieu M, Koch WJ. GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophy. Expert Opin Ther Targets. 2019;23:201\u201314.","journal-title":"Expert Opin Ther Targets"},{"key":"5029_CR5","doi-asserted-by":"publisher","first-page":"E334","DOI":"10.1152\/ajpendo.00084.2012","volume":"303","author":"G Ren","year":"2012","unstructured":"Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab. 2012;303:E334\u2013351.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"5029_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bbalip.2015.11.003","volume":"1861","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Li S, Donelan W, Xie C, Wang H, Wu Q, et al. Angiopoietin-like protein 8 (betatrophin) is a stress-response protein that down-regulates expression of adipocyte triglyceride lipase. Biochim Biophys Acta. 2016;1861:130\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"5029_CR7","doi-asserted-by":"publisher","unstructured":"Abu-Farha M, Abubaker J, Tuomilehto J. ANGPTL8 (betatrophin) role in diabetes and metabolic diseases. Diabetes Metab Res Rev. 2017;33. https:\/\/doi.org\/10.1002\/dmrr.2919.","DOI":"10.1002\/dmrr.2919"},{"key":"5029_CR8","doi-asserted-by":"publisher","first-page":"8293207","DOI":"10.1155\/2017\/8293207","volume":"2017","author":"Y Yin","year":"2017","unstructured":"Yin Y, Ding X, Peng L, Hou Y, Ling Y, Gu M, et al. Increased serum ANGPTL8 concentrations in patients with prediabetes and type 2 diabetes. J Diabetes Res. 2017;2017:8293207.","journal-title":"J Diabetes Res"},{"key":"5029_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10557-019-06924-7","volume":"34","author":"Y Yang","year":"2020","unstructured":"Yang Y, Jiao X, Li L, Hu C, Zhang X, Pan L, et al. Increased circulating angiopoietin-like protein 8 levels are associated with thoracic aortic dissection and higher inflammatory conditions. Cardiovasc Drugs Ther. 2020;34:65\u201377.","journal-title":"Cardiovasc Drugs Ther"},{"key":"5029_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.atherosclerosis.2019.11.011","volume":"293","author":"A Leiherer","year":"2020","unstructured":"Leiherer A, Ebner J, Muendlein A, Brandtner EM, Zach C, Geiger K, et al. High betatrophin in coronary patients protects from cardiovascular events. Atherosclerosis. 2020;293:62\u201368.","journal-title":"Atherosclerosis"},{"key":"5029_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12944-018-0681-0","volume":"17","author":"M Abu-Farha","year":"2018","unstructured":"Abu-Farha M, Cherian P, Qaddoumi MG, AlKhairi I, Sriraman D, Alanbaei M, et al. Increased plasma and adipose tissue levels of ANGPTL8\/Betatrophin and ANGPTL4 in people with hypertension. Lipids Health Dis. 2018;17:35.","journal-title":"Lipids Health Dis"},{"key":"5029_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12944-016-0337-x","volume":"15","author":"M Abu-Farha","year":"2016","unstructured":"Abu-Farha M, Al-Khairi I, Cherian P, Chandy B, Sriraman D, Alhubail A, et al. Increased ANGPTL3, 4 and ANGPTL8\/betatrophin expression levels in obesity and T2D. Lipids Health Dis. 2016;15:181.","journal-title":"Lipids Health Dis"},{"key":"5029_CR13","doi-asserted-by":"publisher","first-page":"5096860","DOI":"10.1155\/2019\/5096860","volume":"2019","author":"J Ye","year":"2019","unstructured":"Ye J, Qin Y, Wang D, Yang L, Yuan G. The relationship between circulating ANGPTL8\/betatrophin concentrations and adult obesity: a meta-analysis. Dis Markers. 2019;2019:5096860.","journal-title":"Dis Markers"},{"key":"5029_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/HYPERTENSIONAHA.114.04806","volume":"65","author":"L Gao","year":"2015","unstructured":"Gao L, Huang K, Jiang DS, Liu X, Huang D, Li H, et al. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy. Hypertension. 2015;65:871\u201381.","journal-title":"Hypertension"},{"key":"5029_CR15","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nm.4179","volume":"22","author":"Z Wang","year":"2016","unstructured":"Wang Z, Zhang XJ, Ji YX, Zhang P, Deng KQ, Gong J, et al. The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy. Nat Med. 2016;22:1131\u20139.","journal-title":"Nat Med"},{"key":"5029_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.116.07741","volume":"69","author":"L Chen","year":"2017","unstructured":"Chen L, Huang J, Ji YX, Mei F, Wang PX, Deng KQ, et al. Tripartite motif 8 contributes to pathological cardiac hypertrophy through enhancing transforming growth factor beta-activated kinase 1-dependent signaling pathways. Hypertension. 2017;69:249\u201358.","journal-title":"Hypertension"},{"key":"5029_CR17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3892\/ijmm.2013.1420","volume":"32","author":"Y Wang","year":"2013","unstructured":"Wang Y, Chen H, Li H, Zhang J, Gao Y. Effect of angiopoietin-like protein 4 on rat pulmonary microvascular endothelial cells exposed to LPS. Int J Mol Med. 2013;32:568\u201376.","journal-title":"Int J Mol Med"},{"key":"5029_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep10949","volume":"5","author":"M Abu-Farha","year":"2015","unstructured":"Abu-Farha M, Abubaker J, Al-Khairi I, Cherian P, Noronha F, Hu FB, et al. Higher plasma betatrophin\/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance. Sci Rep. 2015;5:10949.","journal-title":"Sci Rep"},{"key":"5029_CR19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.bbrc.2012.07.038","volume":"424","author":"R Zhang","year":"2012","unstructured":"Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012;424:786\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"5029_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep28431","volume":"6","author":"H Wang","year":"2016","unstructured":"Wang H, Lai Y, Han C, Liu A, Fan C, Zhang H, et al. The effects of serum ANGPTL8\/betatrophin on the risk of developing the metabolic syndrome - a prospective study. Sci Rep. 2016;6:28431.","journal-title":"Sci Rep"},{"key":"5029_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11010-020-03725-7","volume":"469","author":"R Fadaei","year":"2020","unstructured":"Fadaei R, Shateri H, DiStefano JK, Moradi N, Mohammadi M, Emami F, et al. Higher circulating levels of ANGPTL8 are associated with body mass index, triglycerides, and endothelial dysfunction in patients with coronary artery disease. Mol Cell Biochem. 2020;469:29\u201339.","journal-title":"Mol Cell Biochem"},{"key":"5029_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12933-016-0346-0","volume":"15","author":"M Abu-Farha","year":"2016","unstructured":"Abu-Farha M, Abubaker J, Al-Khairi I, Cherian P, Noronha F, Kavalakatt S, et al. Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome. Cardiovasc Diabetol. 2016;15:25.","journal-title":"Cardiovasc Diabetol"},{"key":"5029_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/MOL.0000000000000600","volume":"30","author":"S Kersten","year":"2019","unstructured":"Kersten S. New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk. Curr Opin Lipido. 2019;30:205\u201311.","journal-title":"Curr Opin Lipido"},{"key":"5029_CR24","doi-asserted-by":"publisher","first-page":"e85078","DOI":"10.1371\/journal.pone.0085078","volume":"9","author":"M van Bilsen","year":"2014","unstructured":"van Bilsen M, Daniels A, Brouwers O, Janssen BJ, Derks WJ, Brouns AE, et al. Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice. PLoS One. 2014;9:e85078.","journal-title":"PLoS One"},{"key":"5029_CR25","doi-asserted-by":"publisher","first-page":"635321","DOI":"10.3389\/fendo.2021.635321","volume":"12","author":"Y Bai","year":"2021","unstructured":"Bai Y, Du Q, Zhang L, Li L, Wang N, Wu B, et al. Silencing of ANGPTL8 alleviates insulin resistance in trophoblast cells. Front Endocrinol. 2021;12:635321.","journal-title":"Front Endocrinol"},{"key":"5029_CR26","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00125-018-4579-1","volume":"61","author":"DF Vatner","year":"2018","unstructured":"Vatner DF, Goedeke L, Camporez JG, Lyu K, Nasiri AR, Zhang D, et al. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents. Diabetologia. 2018;61:1435\u201346.","journal-title":"Diabetologia"},{"key":"5029_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2020.06.014","volume":"307","author":"X Jiao","year":"2020","unstructured":"Jiao X, Yang Y, Li L, Yu H, Li J, Du Y, et al. Angiopoietin-like protein 8 accelerates atherosclerosis in ApoE(-\/)(-) mice. Atherosclerosis. 2020;307:63\u201371.","journal-title":"Atherosclerosis"},{"key":"5029_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4303","volume":"5","author":"DS Jiang","year":"2014","unstructured":"Jiang DS, Wei X, Zhang XF, Liu Y, Zhang Y, Chen K, et al. IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling. Nat Commun. 2014;5:3303.","journal-title":"Nat Commun"},{"key":"5029_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11010-016-2849-0","volume":"424","author":"V Rai","year":"2017","unstructured":"Rai V, Sharma P, Agrawal S, Agrawal DK. Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research. Mol Cell Biochem. 2017;424:123\u201345.","journal-title":"Mol Cell Biochem"},{"key":"5029_CR30","doi-asserted-by":"publisher","first-page":"4860595","DOI":"10.1155\/2016\/4860595","volume":"2016","author":"M Abu-Farha","year":"2016","unstructured":"Abu-Farha M, Al Madhoun A, Abubaker J. The rise and the fall of betatrophin\/ANGPTL8 as an inducer of beta-cell proliferation. J Diabetes Res. 2016;2016:4860595.","journal-title":"J Diabetes Res"},{"key":"5029_CR31","doi-asserted-by":"publisher","first-page":"e20190196","DOI":"10.1590\/1678-4685-gmb-2019-0196","volume":"43","author":"F Taherkhani","year":"2020","unstructured":"Taherkhani F, Hosseini KM, Zebardast S, Chegini KG, Gheibi N. Anti proliferative and apoptotic effects on pancreatic cancer cell lines indicate new roles for ANGPTL8 (Betatrophin). Genet Mol Biol. 2020;43:e20190196.","journal-title":"Genet Mol Biol"},{"key":"5029_CR32","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1007\/s11033-021-06270-8","volume":"48","author":"M Navaeian","year":"2021","unstructured":"Navaeian M, Asadian S, Ahmadpour Yazdi H, Gheibi N. ANGPTL8 roles in proliferation, metabolic diseases, hypothyroidism, polycystic ovary syndrome, and signaling pathways. Mol Biol Rep. 2021;48:3719\u201331.","journal-title":"Mol Biol Rep"},{"key":"5029_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cca.2021.05.017","volume":"519","author":"X Su","year":"2021","unstructured":"Su X, Cheng Y, Wang B. ANGPTL8 in cardio-metabolic diseases. Clin Chim Acta. 2021;519:260\u20136.","journal-title":"Clin Chim Acta"},{"key":"5029_CR34","doi-asserted-by":"publisher","first-page":"16109","DOI":"10.1073\/pnas.1315292110","volume":"110","author":"Y Wang","year":"2013","unstructured":"Wang Y, Quagliarini F, Gusarova V, Gromada J, Valenzuela DM, Cohen JC, et al. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci USA. 2013;110:16109\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5029_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cbi.2019.04.024","volume":"307","author":"L Shang","year":"2019","unstructured":"Shang L, Pin L, Zhu S, Zhong X, Zhang Y, Shun M, et al. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT\/ GSK-3beta signaling pathway. Chem Biol Interact. 2019;307:21\u201328.","journal-title":"Chem Biol Interact"},{"key":"5029_CR36","doi-asserted-by":"publisher","first-page":"14466","DOI":"10.1074\/jbc.275.19.14466","volume":"275","author":"C Morisco","year":"2000","unstructured":"Morisco C, Zebrowski D, Condorelli G, Tsichlis P, Vatner SF, Sadoshima J. The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes. J Biol Chem. 2000;275:14466\u201375.","journal-title":"J Biol Chem"},{"key":"5029_CR37","first-page":"16","volume":"4","author":"M Deng","year":"2021","unstructured":"Deng M, Chen H, Liu X, Huang R, He Y, Yoo B, et al. Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer. Antib Ther. 2021;4:16\u201333.","journal-title":"Antib Ther"},{"key":"5029_CR38","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.aax4040","volume":"368","author":"H Dai","year":"2020","unstructured":"Dai H, Lan P, Zhao D, Abou-Daya K, Liu W, Chen W, et al. PIRs mediate innate myeloid cell memory to nonself MHC molecules. Science. 2020;368:1122\u20137.","journal-title":"Science"},{"key":"5029_CR39","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature11095","volume":"485","author":"J Zheng","year":"2012","unstructured":"Zheng J, Umikawa M, Cui C, Li J, Chen X, Zhang C, et al. Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature. 2012;485:656\u201360.","journal-title":"Nature"},{"key":"5029_CR40","doi-asserted-by":"publisher","first-page":"80391","DOI":"10.18632\/oncotarget.13061","volume":"7","author":"S Chen","year":"2016","unstructured":"Chen S, Chen J, Meng XL, Shen JS, Huang J, Huang P, et al. ANGPTL8 reverses established adriamycin cardiomyopathy by stimulating adult cardiac progenitor cells. Oncotarget. 2016;7:80391\u2013403.","journal-title":"Oncotarget"}],"updated-by":[{"DOI":"10.1038\/s41419-025-07731-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05029-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05029-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05029-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:02:53Z","timestamp":1749319373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05029-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["5029"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05029-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"15 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In this article fig. 1F and 4I have been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-025-07731-9","URL":"https:\/\/doi.org\/10.1038\/s41419-025-07731-9","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human blood samples used in this manuscript and animal experiments were approved by the Center\u2019s Experimental Animal Ethics Committee of Hubei University of Medicine and conducted in accordance with the Helsinki declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"621"}}